| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.77 | 0.003 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |